It is widely acknowledged that medication errors result in thousands of adverse drug events, preventable reactions, and deaths per year. Nurses, physicians, pharmacists, patient safety organizations, the Food and Drug Administration, the pharmaceutical industry, Health Canada, and other parties share in the responsibility for determining how medication errors occur and designing strategies to reduce error.
One impediment to understanding the scope and nature of the problem has been the reactive "blaming, shaming, training" culture that singled out one individual as the cause of the error. Also historically, medication errors that did not result in patient harm near-miss situations in which an error could have but didnt happen or errors that did not result in serious harm were not reported. In contrast, serious errors often instigated a powerful punitive response in which one or a few persons were deemed to be at fault and, as a result, lost their jobs and sometimes their licenses.
In 1999, the Institute of Medicine (IOM) published To Err Is Human: Building a Safer Health System, which drew attention to the problem of medication errors. It pointed out that excellent health care providers do make medication errors, that many of the traditional processes involved in the medication-use system were error-prone, and that other factors, notably drug labeling and packaging, contributed to error. Furthermore, the IOM report, in conjunction with other groups such as the United States Pharmacopeia (USP) and the Institute for Safe Medication Practices (ISMP), called for the redesign of error-prone systems to include processes that anticipated the fallibility of humans working within the system. This initiative is helping shift the way the health care industry addresses medication errors from a single person/bad apple cause to a systems issue.
The National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) developed the definition of a medication error that reflects this shift and captures the scope and breadth of the issue:
"A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use."
Inherent in this definition's mention of related factors are the human factors that are part of the medication use system. For example, a nurse or pharmacist may automatically reach into the bin where dobutamine is usually kept, see "do" and "amine" but select dopamine instead of dobutamine. Working amidst distractions, working long hours or shorthanded, and working in a culture where perfection is expected and questioning is discouraged are other examples of the human factors and environmental conditions that contribute to error.
The goal for the design of any individual or hospital-wide medication use system is to determine where systems are likely to fail and to build in safeguards that minimize the potential for error. One way to begin that process is to become familiar with medications or practices that have historically been shown to be involved in serious errors.
High Alert Medications
Some medications, because of a narrow therapeutic range or inherent toxic nature, have a high risk of causing devastating injury or death if improperly ordered, prepared, stocked, dispensed, administered, or monitored. Although these medications may not be involved in more errors, they require special attention due to the potential for serious, possibly fatal consequences. These have been termed high-alert medications, to communicate the need for extra care and safeguards. Many of these drugs are used commonly in the general population or are used frequently in urgent clinical situations. The Joint Commission (TJC) monitors the use of frequently prescribed high-alert medications, which include insulin, opioids, injectable potassium chloride (or phosphate) concentrate, intravenous anticoagulants (such as heparin), sodium chloride solutions with a concentration greater than 0.9%, and others. Visit the Institute for Safe Medication Practices at www.ismp.org for a complete list of High Alert Drugs.
Causes of Medication Errors
Many contributing factors and discrete causes of error have been identified, including failed communication, poor pharmaceutical supply chain distribution practices, dose miscalculations, drug packaging and drug-device related problems, incorrect drug administration, and lack of patient education.
Failed Communication:
Failed communication covers many of the errors made in the ordering phase, and although ordering is performed by the prescriber, the nurse, the clerk, and the pharmacist who interpret that order are also involved in the communication process.
Several of the sound-alike/look-alike drugs were targeted for labeling intervention by the FDA, which requested manufacturers with look-alike names to voluntarily revise the appearance of the established names. The revision visually differentiates the drug names by using "tall man" letters (capitals) to highlight distinguishing syllables (ex.: buPROPrion versus busPIRone or ceFAZolin versus cefTAZidime. See the TALL MAN Lettering table in the Medication Safety Tools section for the list of the pairs of drugs that are commonly confused, often with serious consequences.
Poor Distribution Practices:
Poor distribution includes error-prone storing practices such as keeping similar-looking products next to each other. Dispensing multidose floor stock vials of potentially dangerous drugs instead of unit (single) dose vials is also associated with error, as is allowing non-pharmacists to dispense medications in the absence of the pharmacist.
Dose Miscalculations:
Dose miscalculations are a prime source of medication error. Also, many medications need to be dose-adjusted for renal or hepatic impairment, age, height and weight, and body composition (i.e., correct for obesity). Complicated dosing formulas provide many opportunities to introduce error. Often vulnerable populations, such as premature infants, children, older adults, and those with serious underlying illnesses, are at greatest risk.
Drug Packaging:
Similar packaging or poorly designed packaging encourages error. Drug companies may use the same design for different formulations, or fail to highlight information about concentration or strength. Lettering, type size, color, and packaging methods can either help or hinder drug identification.
Drug Delivery Systems:
Drug delivery systems include infusion pumps and drip rate controllers. Some models do not prevent free flow of medication, leading to sudden high dose infusion of potent and dangerous medications. The lack of safeguards preventing free flow and programming errors are among the problems encountered with infusion control devices. Newer models, which are integrated with the medication administration record (MAR) via scanned barcodes to match the patient with drug, dose, and timing, contribute to increased dosing safety; however, it is a nursing responsibility to verify the dose and determine that the infusion pump is delivering properly at the point of drug administration.
Incorrect Drug Administration:
Incorrect drug administration covers many problems. Misidentification of a patient, incorrect route of administration, missed doses, or improper drug preparation are types of errors that occur during the administration phase. Barcode scanning to identify the patient and correlate with the correct MAR decreases the likelihood of incorrect drug administration.
Lack of Patient Education:
Safe medication use is enhanced in the hospital and the home when the patient is well informed. The knowledgeable patient can recognize when something has changed in his or her medication regimen and can question the health care professional. At the same time, many issues related to medication errors, such as ambiguous directions, unfamiliarity with a drug, and confusing packaging, affect the patient as well as the health care professional, underscoring the need for careful education. Patient education also enhances adherence, which is a factor in proper medication use.
Prevention Strategies
Since medication use systems are complex and involve many steps and people, they are error-prone. On an individual basis, nurses can help reduce the incidence of error by implementing the following strategies:
Table 1: Abbreviations and Symbols Associated with Medication Errors | |||
Abbreviation/Symbol | Intended Meaning | Mistaken For | Recommendation |
---|---|---|---|
APAP | Acetaminophen | Not recognized as acetaminophen | Use full drug name |
AT II | Angiotensin II | Antithrombin III | Use full drug name |
AT III | Antithrombin III | Angiotensin II | Use full drug name |
AZT | Zidovudine | Azithromycin, azathioprine, aztreonam | Use full drug name |
CPZ | Compazine (prochlorperazine) | Chlorpromazine | Use full drug name |
DOR | Doravirine | Dovato (dolutegravir/lamivudine) | Use full drug name |
HCT | Hydrocortisone | Hydrochlorothiazide | Use full drug name |
HCTZ | Hydrochlorothiazide | Hydrocortisone | Use full drug name |
IV vanc | Intravenous vancomycin | Invanz (ertapenem) | Use full drug name |
"Levo" | Levofloxacin | Levophed (norepinephrine) | Use full drug name |
MgSO4* | Magnesium sulfate | Morphine sulfate | Use full drug name |
MS or MSO4* | Morphine sulfate | Magnesium sulfate | Use full drug name |
MTX | Methotrexate | Mitoxantrone | Use full drug name |
Na at the beginning of a drug name (e.g., Na bicarbonate) | Sodium bicarbonate | No bicarbonate | Use full drug name |
"Nitro" drip | Nitroglycerin infusion | Nitroprusside infusion | Use full drug name |
NoAC | Novel/new oral anticoagulant | No anticoagulant | Use full drug name |
OXY | Oxytocin | Oxycodone, Oxycontin | Use full drug name |
PCA | Procainamide | Patient controlled analgesia | Use full drug name |
PIT | Pitocin (oxytocin) | Pitressin (vasopressin) | Use full drug name |
PNV | Prenatal vitamins | Penicillin VK | Use full drug name |
PTU | Propylthiouracil | Mercaptopurine | Use full drug name |
T3 | Tylenol with codeine no. 3 | Liothyronine | Use full drug name |
TAC or tac | Triamcinolone or tacrolimus | Tetracaine, Adrenalin, cocaine, Taxotere, Adriamycin, cyclophosphamide | Use full drug name |
TAF | Tenofovir alafenamide | Tenofovir disoproxil fumarate | Use full drug name |
TDF | Tenofovir disoproxil fumarate | Tenofovir alafenamide | Use full drug name |
TNK | TNKase | tPA | Use full drug name |
TPA or tPA | Tissue plasminogen activator (alteplase) | TNKase (tenecteplase), TXA (tranexamic acid), Retevase (reteplase) | Use full drug name |
TXA | Tranexamic acid | tPA | Use full drug name |
ZnSO4 | Zinc sulfate | Morphine sulfate | Use full drug name |
g | Microgram | mg (milligram) | Use "mcg" |
AD, AS, or AU | Right ear, left ear, both ears | Right eye, left eye, both eyes | Spell out "right ear," "left ear," or "both ears" |
BIW or biw | 2 times a week | 2 times a day | Spell out "2 times weekly" |
cc | cubic centimeters | u (units) | Use "ml" |
D/C | Discharge or discontinue | One mistaken for the other | Spell out "discharge" or "discontinue" |
HS or hs | Half strength or hours of sleep (at bedtime) | One mistaken for the other | Spell out "half strength" or use "HS" for at bedtime |
IN | Intranasal | IM or IV | Spell out "intranasal" or use "NAS" |
IT | Intrathecal | Intratracheal, intratumor, intratympanic, inhalation therapy | Spell out "intrathecal" |
IU* | International Units | IV or 10 | Spell out "units" |
l | Liter | 1 (one) | Use uppercase "L" |
M or K | Thousand | Million | Spell out "thousand" |
ml | Milliliter | 1 (one) | Use "mL" (with lowercase "m" and uppercase "L") |
MM or M | Million | Thousand | Spell out "million" |
Ng or ng | Nanogram | mg (milligram) or nasogastric | Spell out "nanogram" |
OD, OS, or OU | Right eye, left eye, both eyes | Right ear, left ear, both ears | Spell out "right eye," "left eye," or "both eyes" |
o.d. or OD | Once daily | Right eye | Spell out "daily" |
OJ | Orange juice | OD (right eye), OS (left eye) | Spell out "orange juice" |
q.d., qd, Q.D., or QD* | Every day | qid (4 times per day) | Spell out "daily" |
q1d | Daily | qid (4 times per day) | Spell out "daily" |
Qhs | Nightly at bedtime | qhr (every hour) | Spell out "nightly" or use "HS" for bedtime |
q.o.d., qod, Q.O.D, or QOD* | Every other day | qid (4 times per day) or qd (daily) | Spell out "every other day" |
SC, SQ, sq, or sub q | Subcutaneously | SC mistaken as SL (sublingual); SQ mistaken as "5 every"; q in sub q mistaken as "every" | Use "SUBQ" or write out "subcutaneously" |
SSRI | Sliding scale regular insulin | Selective serotonin reuptake inhibitor | Spell out "sliding scale insulin" |
TIW or tiw | 3 times a week | 3 times a day or twice a week | Spell out "3 times weekly" |
u or U* | units | 0 (zero), 4 (four) or cc | Spell out "units" |
UD | As directed | Unit dose | Spell out "as directed" |
/ (slash mark) | Per" | 1 (one) | Spell out "per" |
+ | Plus sign | 4 (four) | Spell out "and" |
Zero after a decimal point (e.g., 1.0 mg)* | 1 mg | 10 mg | DO NOT USE zero after a decimal point |
No zero before a decimal point (e.g., .1 mg)* | .1 mg | 1 mg | ALWAYS USE zero before a decimal point |
@ | At | 2 (two) | Use "at" |
> | Greater than | < | Spell out "greater than" |
< | Less than | 4 or > | Spell out "less than" |
& | And | 2 (two) | Use "and" |
° | Hour | Zero | Use "hr," "h," or "hour" |
Drug name and dose run together. Example: Inderal 40 mg | Inderal 40 mg | Inderal 140 mg | Leave space between drug name, dose, and unit of measure |
Numerical dose and unit of measure run together. Example: 10 mg | 10 mg | 100 mg | Leave space between drug dose and unit of measure |
Appears on The Joint Commission's "Do Not Use" list of abbreviations.Modified from ISMP's List of Error-Prone Abbreviations, Symbols, and Dose Designations, 2021. |